TABLE 3.
Main studies dealing with the effects of Akkermansia muciniphila in bodyweight management.
Study | Disease | Design | Size | Patients | Length | Outcomes |
---|---|---|---|---|---|---|
Dao et al. (2019) | Obesity | Non-randomised prospective study | 65 | Adults | 12 months | A. muciniphila abundance does not affect glucose tolerance and insulin sensitivity in patients after gastric bypass surgery |
Shin NR (2014) | Healthy | Animal study | 24 | HFD-fed mice | 6 weeks | A. muciniphila administration reduse adipose tissue inflammation |
Depommier et al. (2019) | Overweight and obesity | Randomised double blind study | 32 | Adults | 3 months | Increased A. muciniphila abundance negatively correlates with insulin resistance, inflammation markers and liver disfunction markers |
Dao (2016) | Overweight and obesity | Randomised control study | 49 | Adults | 3 months | Increased A. muciniphila abundance positively correlates with insulin sensitivity |
Cao et al. (2023) | Obesity | Randomised double blind study | 37 | Adults | 4 months | Increased A. muciniphila abundance positively correlates with weight loss |